AKADEEMILINE ÕENDUSLUGU
K. Ausmees, M. Zarkovski, G. Timberg, et al. Prevalence of inflammatory prostatitis
in ageing male with lower urinary tract symptoms. Eur Urol 2009;8:5856.
Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the
health professionals followup study cohort. J Urol 2002;167:13636.
Daniels NA, Ewing SK, Zmuda JM, et al. Correlates and prevalence of prostatitis in a
large community-based cohort of older men. Urol 2005;66:96470.
Di Silverio F, Gentile V, De Matteis A, et al. Distribution of inf lammation, pre-
malignant lesions, incidental carcinoma in histologically confirmed benign prostatic
hyperplasia: a retrospec tive analysis. Eur Urol 2003;43:16475.
Gleason PE, Jones JA, Regan JS, et al. Platelet derived growth factor, a ndrogens and
inflammation: possible etiologic factors in the development of prostatitis
hyperplasia. J Urol 1993;149:158690.
Kramer G, Steiner GE, Handisurya A, et al. Increased expression of lymphocyte-
annaabi.ee 
